A pilot study of EVAP/ABV chemotherapy in 25 newly diagnosed children with Hodgkin's disease.

Twenty five children with newly diagnosed Hodgkin's disease were clinically staged and treated with a chemotherapy protocol designed to reduce delayed toxicity. Four patients without macroscopic residual disease after biopsy received three cycles of hybrid EVAP/ABV. All remain in CR 31-46 month...

Descripción completa

Detalles Bibliográficos
Autores principales: Ekert, H., Fok, T., Dalla-Pozza, L., Waters, K., Smith, P., White, L.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1993
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968223/
https://www.ncbi.nlm.nih.gov/pubmed/7678978

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968223/
https://www.ncbi.nlm.nih.gov/pubmed/7678978

Ejemplares similares